News

More patients will have access to potentially life-saving cancer therapies as a result of Epworth joining forces with Cancer Trials Australia. With the addition of Epworth, CTA now has [...]

I am pleased to share the 2016 Cancer Trials Australia 2016 Annual Report. Download the 2016 Annual Report Here. 2016 saw growth in CTA membership and corresponding CTA service activity. [...]

Cancer Trials Australia (CTA) is pleased to announce that Linear Clinical Research has signed a Members Agreement to join the CTA Member Network The CTA network now includes 24 [...]

Cancer Trials Australia (CTA) is proud to be part of the successful Cancer Council Victoria (CCV) grant application for the establishment of a cancer clinical trials network across seven [...]

Chairman of the Board, Professor Andrew Scott, with great pleasure advised that the next Chief Executive Officer of Cancer Trials Australia (CTA) will be Dr Kurt Lackovic. Professor Scott said [...]

Cancer Trials Australia (CTA) announced today that the Shepparton Hospital, through Goulburn Valley Health, and Northern Adelaide Cancer Centre Clinical Trials Unit, operating as the Lyell McEwin Hospital, have [...]

A new RAF-targeted therapeutic has shown early promise against tumours in Phase 1 trials. Doctors Jayesh Desai (1), Ben Solomon (2) and Hui Gan (3)have established a highly successful collaboration [...]

Cancer Trials Australia (CTA) announced today that South West Healthcare had signed an agreement to join CTA. "Southwest Healthcare located at Warrnambool in Victoria services a large population over South [...]

The Board of Directors of Cancer Trials Australia (CTA) today announced the appointment of Professor Andrew Scott as Chairperson.This appointment was made by the Board following the resignation of Professor [...]